HopeStage
Back to all studies
CompletedNCT01202604

A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolarity I and II.

Observational studyAges 18–65Greece
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Aigio and 32 more locationsSee all locations and recruitment
Study clarity

Study information

Study start dateSeptember 2010
Recruitment status
Completed
Enrollment listed in the registry
294
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
Greece
Age range
From 18 Years to 65 Years
Official registry ID
NCT01202604
Official title
Show the full official title

Prospective, Observational Study for the Maintenance Treatment of Patients With Bipolar Disorder I and II in Greece.

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Aigio · Ag. Paraskevi · Athens

30 more locations
  • Chaïdári
  • Drapetsona
  • Elefsina
  • Glyfada
  • Ilissia
  • Kifissia
  • Koropí
  • Marousi
  • N. Kosmos
  • Pangrati
  • Petroúpolis
  • Piraeus
  • Thebes
  • Vironas
  • Ag. Nikolaos
  • Agrinio
  • Arta
  • Alexandroupoli
  • Lamia
  • Amaliáda
  • Karditsa
  • Katerini
  • Kavala
  • Sparti
  • Edessa
  • Giannitsá
  • Preveza
  • Serres
  • Thessaloniki
  • Trikala
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies